Actively Recruiting

Phase Not Applicable
Age: 0Years - 21Years
All Genders
Healthy Volunteers
NCT07223177

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Led by Masimo Corporation · Updated on 2026-03-04

100

Participants Needed

2

Research Sites

24 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.

CONDITIONS

Official Title

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Who Can Participate

Age: 0Years - 21Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject falls within the indicated population for the Philips FAST SpO2 Monitor with the Masimo sensor.
  • Subject is less than 22 years of age (pediatric subject per US FDA definition).
Not Eligible

You will not qualify if you...

  • Subject has a skin condition or deformity at the planned sensor application site preventing sensor placement (e.g., psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown).
  • Confounders of pulse oximetry per sensor direction for use.
  • Subject with distinct geographic variances in skin pigmentation (e.g., vitiligo) where the sensor is applied.
  • Subject has absence or deformities of limbs or severe edema interfering with sensor application or proper fit.
  • Subject with nail polish or acrylic nails on digits where sensor needs to be applied who refuses removal.
  • Subject with known allergic reactions to adhesive tapes.
  • Subject deemed unsuitable for investigation by the clinical research team.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Paradigm Clinical Research

Modesto, California, United States, 95355

Actively Recruiting

2

Paradigm Clinical Research

San Diego, California, United States, 92108

Actively Recruiting

Loading map...

Research Team

C

Chelsea Frank

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations | DecenTrialz